Anti-FRS2/ FRS1AA/ FRS2alpha monoclonal antibody

Anti-FRS2/ FRS1AA/ FRS2alpha antibody for FACS & in-vivo assay

Target products collectionGo to FRS2/FRS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2132-Ab-1/ GM-Tg-hg-MP2132-Ab-2Anti-Human FRS2 monoclonal antibodyHuman
GM-Tg-rg-MP2132-Ab-1/ GM-Tg-rg-MP2132-Ab-2Anti-Rat FRS2 monoclonal antibodyRat
GM-Tg-mg-MP2132-Ab-1/ GM-Tg-mg-MP2132-Ab-2Anti-Mouse FRS2 monoclonal antibodyMouse
GM-Tg-cynog-MP2132-Ab-1/ GM-Tg-cynog-MP2132-Ab-2Anti-Cynomolgus/ Rhesus macaque FRS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2132-Ab-1/ GM-Tg-felg-MP2132-Ab-2Anti-Feline FRS2 monoclonal antibodyFeline
GM-Tg-cang-MP2132-Ab-1/ GM-Tg-cang-MP2132-Ab-2Anti-Canine FRS2 monoclonal antibodyCanine
GM-Tg-bovg-MP2132-Ab-1/ GM-Tg-bovg-MP2132-Ab-2Anti-Bovine FRS2 monoclonal antibodyBovine
GM-Tg-equg-MP2132-Ab-1/ GM-Tg-equg-MP2132-Ab-2Anti-Equine FRS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2132-Ab-1/ GM-Tg-hg-MP2132-Ab-2; GM-Tg-rg-MP2132-Ab-1/ GM-Tg-rg-MP2132-Ab-2;
GM-Tg-mg-MP2132-Ab-1/ GM-Tg-mg-MP2132-Ab-2; GM-Tg-cynog-MP2132-Ab-1/ GM-Tg-cynog-MP2132-Ab-2;
GM-Tg-felg-MP2132-Ab-1/ GM-Tg-felg-MP2132-Ab-2; GM-Tg-cang-MP2132-Ab-1/ GM-Tg-cang-MP2132-Ab-2;
GM-Tg-bovg-MP2132-Ab-1/ GM-Tg-bovg-MP2132-Ab-2; GM-Tg-equg-MP2132-Ab-1/ GM-Tg-equg-MP2132-Ab-2
Products NameAnti-FRS2 monoclonal antibody
Formatmab
Target NameFRS2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FRS2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FRS2/ FRS1AA/ FRS2alpha VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP2132-Ag-1fibroblast growth factor receptor substrate 2 (FRS2) protein
    ORF Viral VectorvGMLP002758human FRS2 Lentivirus particle
    ORF Viral VectorpGMLP002758human FRS2 Lentivirus plasmid


    Target information

    Target IDGM-MP2132
    Target NameFRS2
    Gene ID10818,327826,314850,717117,474444,101099133,538624,100052205
    Gene Symbol and SynonymsC330018A15Rik,FRS1A,FRS2,FRS2-alpha,FRS2A,FRS2alpha,SNT,SNT-1,SNT1
    Uniprot AccessionQ8WU20
    Uniprot Entry NameFRS2_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000166225
    Target ClassificationN/A

    The target: FRS2, gene name: FRS2, also named as FRS1AA, FRS2alpha, SNT, SNT-1, SNT1, FRS2. Enables fibroblast growth factor receptor binding activity and neurotrophin TRKA receptor binding activity. Involved in negative regulation of cardiac muscle cell differentiation. Acts upstream of or within fibroblast growth factor receptor signaling pathway. Located in adherens junction. Biomarker of renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.